GenoTher Information

With 68 DNA or RNA gene therapies approved, of which 48 in just the past five years, gene therapy has emerged as a transformative frontier in medicine. Harnessing this potential, the French government has taken a decisive step forward by funding the creation of GenoTher, the first European biocluster exclusively dedicated to gene therapy, under the ambitious France 2030 initiative. 🌍 Located in Paris and Evry, GenoTher is set to become a global hub for innovation, bringing together leading researchers, clinicians, industry leaders, and policymakers to accelerate the development of groundbreaking therapies. 🔬 Our Mission GenoTher is committed to tackling the critical challenges in gene therapy and creating a fertile ecosystem for innovation. Our objectives are: • 🧬 Driving therapeutic and technological innovation to tackle current and future critical challenges in gene therapy, • 🏗️ Providing state-of-the-art platforms, supporting every stage from discovery to clinical trials and market approval, • 🎓 Foster training and talent development to secure a future-ready workforce, • 🚀 Accelerating the growth of high-potential companies and advancing France leadership in this rapidly evolving field. 🤝 A Collaborative Ecosystem for Excellence GenoTher unites world-class researchers, biotechnology pioneers, academic institutions, hospitals, and investors in a dynamic and patient-focused ecosystem. By facilitating collaboration, providing access to cutting-edge technologies, and promoting translational research, we aim to bridge the gap between discovery and application. 🌟 Our Vision GenoTher aspires to position France and Europe at the forefront of global gene therapy innovation, transforming lives and reshaping the future of healthcare. Join us as we work to unlock the potential of gene therapy and deliver life-changing treatments for patients worldwide. 🌱🔬